Latest: FDA Approves New Biosimilar for Oncology Treatment

Understanding Atopic Dermatitis as an Immune-Mediated Disease

22 August, 2025

0 Mins

Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial populations.

Tags:

Author

American Journal Managed Care

Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius

CDC advisory panel member no longer trusts CDC

📢

300x250 Banner

Understanding Atopic Dermatitis as an Immune-Mediated Disease

Tags:

American Journal Managed Care

Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius

CDC advisory panel member no longer trusts CDC

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition